Journal
NEW BIOTECHNOLOGY
Volume 78, Issue -, Pages 42-51Publisher
ELSEVIER
DOI: 10.1016/j.nbt.2023.10.001
Keywords
Droplet digital PCR; Cell line development; Genetic characterization; Cell bank characterization; Difficult-to-express protein; Prediction of molecule assembly
Ask authors/readers for more resources
PCR-based methods, especially droplet digital PCR (ddPCR), have important applications in cell line development. This study demonstrates the use of ddPCR for precise quantification of transgene copies and prediction of assembly and homogeneity of difficult-to-express proteins. The implementation of ddPCR-based assays improves the robustness and comparability of genomic characterization.
Molecular biological methods have emerged as inevitable tools to accompany the process of cell line development for the generation of stable and highly productive manufacturing cell lines in the biopharmaceutical industry. PCR-based methods are especially useful for screening and characterization of cell lines due to their low cost, scalability, precision and propensity for multidimensional read-outs. In this study, the diverse applications of droplet digital PCR (ddPCR) as a molecular biological tool for cell line development are demonstrated. Specifically, it is shown that ddPCR can be used to enable precise, sensitive and reproducible absolute quantification of genomically integrated transgene copies during cell line development and cell bank characterization. Additionally, an amplitude multiplexing approach is applied to simultaneously run multiple assays on different genetic targets in a single reaction and advance clonal screening by measuring gene expression profiles to predict the assembly and homogeneity of difficult-to-express (DTE) proteins. The implementation of ddPCR-based assays during cell line development allows for early screening at a transcriptional level, particularly for complex, multidomain proteins, where balanced polypeptide chain ratios are of primary importance. Moreover, it is demonstrated that ddPCR-based genomic characterization improves the robustness, efficiency and comparability of absolute transgene copy number quantification, an essential genetic parameter that must be demonstrated to regulatory authorities during clinical trial and market authorization application submissions to support genetic stability and consistency of the selected cell substrate.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available